SAN DIEGO, July 17, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (“Apricus Bio”) (Nasdaq:APRI) (www.apricusbio.com) today issued the following statement regarding the registration of 3,706,397 shares of the Company’s common stock on U.S. Securities and Exchange Commission resale Form S-3, filed yesterday, July 16, 2012:
